Visiomed group - H4 - 25/01 next resistance to break 0.27, i think
Boeing is looking to breakout the downtrend here. It has been doing this pattern and breakouts ever since the covid crash and we have another instance here. BA has consistently been creating these downward wedge patterns and breaking out. With the increase in vaccinations and covid issues starting to decline, and businesses and travel opening back up, this could...
Earnings is Aug 26th. 1. The CEO just dumped 1/3 (100,000) of his shares Friday Aug 20th, leaving him with 200k shares. 2. Weekly chart - Bearish Head and shoulders pattern. 3. Earnings - Last quarter, they beat EPS and revenue, but guided revs lower for next Q. Most of USA was open during this quarter, probably less sales. I think if there is another lockdown,...
This could be an important area for SRNE right now. You've got Fibs and major moving averages all converging at the same point. News today: "Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain and COVID-19, announced today the availability of a...
- In 2015 China had a retail boom-bust 🔥 - It did not take long for retail to find out who was going to hold that bag 💰 - Covid, tech, and monetary policy in the US have conspired to create another retail frenzy ⛈ - I attempt to overlay 2015's fundamentals, technicals, and psychology to the current scenario 🏹 - Just a little observation and thought-experiment...
Biotech sector is getting hot, especially for companies connected to COVID-19 vaccine and treatments development... BIOV chart looks rip for a breakout with MACD closing in on bullish cross and a major catalyst in the form of FDA approval of its Phase I/II study: FDA Provides Necessary Guidance For BioVaxys To Begin Preparation Of Ind For Phase I/II Clinical...
AEMD seems to like this range between the 786 and 618 fib lines. The 618 has long-been a point of resistance on the chart. Meanwhile, the last few days have seen it test the 786 level but hold both above it AND its 50DMA. No news today but focus on biotechs thanks to CYTK earlier could be a sympathy trigger at play. Also with the Delta varient becoming "a...
Model has given entry signals for CSL Limited: - CSL Limited is a global specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. - We are very excited about opportunities in the biotech sector, as we believe the fight against COVID is going to move to the next phase in...
KNR has been beaten down but looks way overdone, given they have just raised $8.5 at 1.50 with institutional investors. The company reported respectable $3.3M revenues in Q1 2021. Their BioCloud COVID-19 detection device will be used by the Canadian Olympic delegation at the Tokyo Olympics. The US sales channel is being worked on. Insiders are buying in the open...
UPI is ridiculously undervalued at $15M mkt cap and is a potential multi-bagger candidate from these levels. - Close to $10M in revenue in 2020 and is on pace to at least double it — recorded $1M in sales in the first week of June! - Profitable, no debt - Exclusive distributor of the 20-second non-invasive (finger scan) COVID-19 test that is currently undergoing...
Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants Expanding existing COVID-19 vaccine research collaboration which began in July 2020. Medytox and Dyadic to co-develop C1 enabled COVID-19 vaccines and/or boosters which will immunize people against two or more of the current and future COVID-19 variants (e.g., tetravalent or quadrivalent COVID-19...
SuperCom Wins COVID-19 Quarantine Compliance Project with the Israeli Government Valued at an Estimated $3 Million per Month in Recurring Revenues Initial project term of 3 months, with potential extension for up to 36 months This nationwide project is expected to commence next week, along with contract signing, for an initial term of 3 months, with an option to...
New Phase 3 Clinical Study Finds Nutritional Protocol Including Nicotinamide Riboside Accelerates Recovery in Mild-to-Moderate COVID-19 Patients New Phase 3 study results show added nutritional protocol reduces recovery time in mild-to-moderate COVID-19 patients The addition of the nutritional protocol, or combined metabolic activators (CMA), to the Turkish...
UPI is a fundamentally strong company with $10M in year revs and only $22M mkt cap. They're selling various COVID-19 detection tech and are also in air sanitation business. Today's news adds to their portfolio nicely: Universal PropTech Inc. Invests in and Secures defined Agency Rights for ISBRG Corp.'s SpotLight-19(C) Technology Designed to Detect Covid-19...
Why $IFMK Skyrocketed in February There does not appear to be any direct news from the company. But it seems like that there was some coordination by day traders on social media. $IFMK shares were buoyed — thanks to discussions and speculation on Twitter and Twitter hashtags at the start of the month. iFresh Inc is an Asian/Chinese grocery supermarket chain in...
T2 Biosystems T2SARS-CoV-2™ Panel Proves Capable of Detecting the Brazil P.1 Variant of the SARS-CoV-2 Virus Panel is capable of detecting 99.99% of all currently identified SARS-CoV-2 viruses based on sequence alignments and in silico analysis. finance.yahoo.com
OCGN: What do they do: mainly focus on developing eye disease therapy. they stepped into the Covid vaccine play and they have a strong product coming – COVAXIN –get this : vaccine can be at room temperature that is huge! transporting and storing with cooling can triple the costs and Pfizer’s vaccine has to be in cooling conditions and if I am not mistaken –...
TYME Granted U.S. Patent Claims Covering Use of TYME-19 to Treat COVID-19 Infections TYME announced that it has received notification that the United States Patent and Trademark Office has granted additional patent claims related to the Company’s metabolomic technology platform. The patent, U.S. Patent No. 10,905,698, is directed to methods for treating...